CMS’s Final Rule Impacting Star Ratings Puts Outcomes In Focus — Are Health Plans Ready to Take Action?

This is a great opportunity to align your strategies with CMS’s evolving framework by refining care models to focus on impact, investing in digital capabilities that support data use, and continuing to build infrastructure that addresses disparities in care. The post CMS’s Final Rule Impacting Star Ratings Puts Outcomes In Focus — Are Health Plans…

Read More

Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test

Eli Lilly obesity drug Zepbound led to 47% greater relative weight loss compared to Wegovy in a head-to-head clinical trial. The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitive market of obesity medications. The post Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head…

Read More

3 Healthcare Trends to Watch in 2025, Per Red Cell Partners

Leaders from Red Cell Partners, an investment and incubation firm that funds and builds healthcare startups, shared key trends they’re keeping their eyes on this year — including increased adoption of AI agents and redefined GLP-1 management frameworks for employers. The post 3 Healthcare Trends to Watch in 2025, Per Red Cell Partners appeared first…

Read More